Aducanumab Approved As The First New Drug Therapy For Alzheimer's Patients In 18 Years
Two recent articles showed showed changes in the focus and funding of clinical trials for Alzheimer's disease therapies.
And they suggested the change might be evidenced by today, when the U.S. Food…